|
1
|
Lu Q, Qiu X, Hu N, Wen H, Su Y and
Richardson BC: Epigenetics, disease, and therapeutic interventions.
Ageing Res Rev. 5:449–467. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song SH, Han SW and Bang YJ:
Epigenetic-based therapies in cancer: progress to date. Drugs.
71:2391–2403. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carew JS, Giles FJ and Nawrocki ST:
Histone deacetylase inhibitors: mechanisms of cell death and
promise in combination cancer therapy. Cancer Lett. 269:7–17. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mariadason JM: HDACs and HDAC inhibitors
in colon cancer. Epigenetics. 3:28–37. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ashktorab H, Belgrave K, Hosseinkhah F,
Brim H, Nouraie M, Takkikto M, Hewitt S, Lee EL, Dashwood RH and
Smoot D: Global histone H4 acetylation and HDAC2 expression in
colon adenoma and carcinoma. Dig Dis Sci. 54:2109–2117. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Emanuele S, Lauricella M and Tesoriere G:
Histone deacetylase inhibitors: apoptotic effects and clinical
implications (Review). Int J Oncol. 33:637–646. 2008.PubMed/NCBI
|
|
7
|
Wagner JM, Hackanson B, Lübbert M and Jung
M: Histone deacetylase (HDAC) inhibitors in recent clinical trials
for cancer therapy. Clin Epigenetics. 1:117–136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
9
|
Migliore L, Migheli F, Spisni R and
Coppedè F: Genetics, cytogenetics, and epigenetics of colorectal
cancer. J Biomed Biotechnol. 2011:7923622011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rius M and Lyko F: Epigenetic cancer
therapy: rationales, targets and drugs. Oncogene. 31:4257–4265.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cameron EE, Bachman KE, Myöhänen S, Herman
JG and Baylin SB: Synergy of demethylation and histone deacetylase
inhibition in the re-expression of genes silenced in cancer. Nat
Genet. 21:103–107. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thakur VS, Gupta K and Gupta S: Green tea
polyphenols causes cell cycle arrest and apoptosis in prostate
cancer cells by suppressing class I histone deacetylases.
Carcinogenesis. 33:377–384. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H,
Welsh W and Yang CS: Tea polyphenol (-)-epigallocatechin-3-gallate
inhibits DNA methyltransferase and reactivates methylation-silenced
genes in cancer cell lines. Cancer Res. 63:7563–7570.
2003.PubMed/NCBI
|
|
14
|
Fini L, Selgrad M, Fogliano V, Graziani G,
Romano M, Hotchkiss E, Daoud YA, De Vol EB, Boland CR and
Ricciardiello L: Annurca apple polyphenols have potent
demethylating activity and can reactivate silenced tumor suppressor
genes in colorectal cancer cells. J Nutr. 137:2622–2628. 2007.
|
|
15
|
Fang MZ, Chen D, Sun Y, Jin Z, Christman
JK and Yang CS: Reversal of hypermethylation and reactivation of
p16INK4a, RARbeta, and MGMT genes by genistein and other
isoflavones from soy. Clin Cancer Res. 11:7033–7041. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shu L, Khor TO, Lee JH, Boyanapalli SSS,
Huang Y, Wu TY, Saw CL, Cheung KL and Kong AN: Epigenetic CpG
demethylation of the promoter and reactivation of the expression of
Neurog1 by curcumin in prostate LNCaP cells. AAPS J. 13:606–614.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan G, Graham K and Lanza-Jacoby S:
Curcumin enhances the anticancer effects of trichostatin a in
breast cancer cells. Mol Carcinog. Jan 30–2012.(Epub ahead of
print).
|
|
18
|
Lah JJ, Cui W and Hu KQ: Effects and
mechanisms of silibinin on human hepatoma cell lines. World J
Gastroenterol. 13:5299–5305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cui W, Gu F and Hu KQ: Effects and
mechanisms of silibinin on human hepatocellular carcinoma
xenografts in nude mice. World J Gastroenterol. 15:1943–1950. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mateen S, Raina K, Jain A, Agarwal C, Chan
D and Agarwal R: Epigenetic modifications and p21-cyclin B1 nexus
in anticancer effect of histone deacetylase inhibitors in
combination with silibinin on non-small cell lung cancer cells.
Epigenetics. 7:1161–1172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kauntz H, Bousserouel S, Gossé F and Raul
F: Silibinin triggers apoptotic signaling pathways and autophagic
survival response in human colon adenocarcinoma cells and their
derived meta-static cells. Apoptosis. 16:1042–1053. 2011.
View Article : Google Scholar
|
|
22
|
Kauntz H, Bousserouel S, Gossé F,
Marescaux J and Raul F: Silibinin, a natural flavonoid, modulates
the early expression of chemoprevention biomarkers in a preclinical
model of colon carcinogenesis. Int J Oncol. 41:849–854.
2012.PubMed/NCBI
|
